Omniscient develops AI and data-driven solutions to improve treatment for brain disorders, providing predictive analytics for clinicians.
Omniscient Neurotechnology has raised $13.4M in total funding. The most recent round was Series D. The last funding was announced in January 2026.
Omniscient Neurotechnology's investors include OIF Ventures, Base Capital, National Reconstruction Fund Corporation, Gina Rinehart, Will Vicars.
Omniscient Neurotechnology is headquartered in Sydney, Australia.
Omniscient develops AI and data-driven solutions to improve treatment for brain disorders, providing predictive analytics for clinicians.
Omniscient Neurotechnology is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Omniscient Neurotechnology — Funding & Investors." VCBacked, January 16, 2026, https://www.vcbacked.co/company/omniscient-neurotechnology. Accessed July 19, 2026.
VCBacked. (2026). Omniscient Neurotechnology — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/omniscient-neurotechnology
{{cite web |title=Omniscient Neurotechnology — Funding & Investors |url=https://www.vcbacked.co/company/omniscient-neurotechnology |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated